Skip to main content
Top

Diabetologia

Issue 4/2000

Content (19 Articles)

Articles

Erythromycin improves glycaemic control in patients with Type II diabetes mellitus

N. Ueno, A. Inui, A. Asakawa, F. Takao, S. Tani, Y. Komatsu, Z. Itoh, M. Kasuga

Rapid communication

Free and protein bound leptin are distinct and independently controlled factors in energy regulation

G. Brabant, R. Horn, A. von zur Mühlen, B. Mayr, U. Wurster, F. Heidenreich, D. Schnabel, A. Grüters-Kieslich, T. Zimmermann-Belsing, U. Feldt-Rasmussen

Rapid communication

Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms β2 and θ

V. Strack, A. M. Hennige, J. Krützfeldt, B. Bossenmaier, H. -H. Klein, M. Kellerer, R. Lammers, H. -U. Häring

Rapid communication

Genetic and immunological characteristics of Type I diabetes mellitus in an Indo-Aryan population

M. A. Kelly, N. S. Alvi, N. J. Croft, C. H. Mijovic, G. F. Bottazzo, A. H. Barnett

Rapid communication

Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren

P. Kulmala, J. Rahko, K. Savola, P. Vähäsalo, R. Veijola, M. Sjöroos, A. Reunanen, J. Ilonen, M. Knip

Rapid communication

Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice

G. S. Korbutt, W. L. Suarez-Pinzon, R. F. Power, R. V. Rajotte, A. Rabinovitch

Rapid communication

Cloning and quantitative determination of the human Ca2+/calmodulin-dependent protein kinase II (CaMK II) isoforms in human beta cells

H. Rochlitz, A. Voigt, B. Lankat-Buttgereit, B. Göke, H. Heimberg, M. A. Nauck, U. Schiemann, H. Schatz, A. F. H. Pfeiffer

Short communication

Response of Charcot's arthropathy to contact casting: assessment by quantitative techniques

M. McGill, L. Molyneaux, T. Bolton, K. Ioannou, R. Uren, D. K. Yue

Short communication

Very low density lipoprotein subfractions in Type II diabetes mellitus: alterations in composition and susceptibility to oxidation

J. McEneny, M. J. O'Kane, K. W. Moles, C. McMaster, D. McMaster, C. Mercer, E. R. Trimble, I. S. Young

Short communication

Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing

A. Kamal, G. J. Biessels, S. E. J. Duis, W. H. Gispen

Short communication

Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes

G. Gambelunghe, M. Ghaderi, A. Cosentino, Ad. Falorni, P. Brunetti, Al. Falorni, C. B. Sanjeevi

Short communication

Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus

L. M. ’t Hart, J. M. Dekker, T. W. van Haeften, J. B. Ruige, C. D. A. Stehouwer, D. W. Erkelens, R. J. Heine, J. A. Maassen

Short communication

R127W-HNF-4α is a loss of function mutation but not a rare polymorphism and causes Type II diabetes in a Japanese family with MODY1

Q. Yang, K. Yamagata, K. Yamamoto, Y. Cao, J. Miyagawa, A. Fukamizu, T. Hanafusa, Y. Matsuzawa

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine